Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Milstien

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Developments in Biologicals|April 8, 2003
Regulatory processes and three Rs alternativesJ Milstien
Indian Pediatrics|February 15, 2001
Vaccine vial monitorsJ Milstien
Lancet (London, England)|April 23, 1999
Immunogenicity of low-dose plasma-derived hepatitis B vaccineM Kane, J Milstien
Developments in Biologicals|April 8, 2003
Implementation of three Rs methods in 3rd World countriesJ L Di Fabio, J Milstien
Vaccine|August 1, 1997
A systematic method for evaluating the potential viability of local vaccine producersJ Milstien, A Batson, W Meaney
Tropical and Geographical Medicine|January 1, 1993
A global overview and hope for the eradication of poliomyelitis by the year 2000N Ward, J Milstien, H Hull, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|July 1, 1978
Characteristics of bacteriophage phiV-1 isolated from live virus vaccinesR Haselkorn, S Schichman, J Milstien, et al.
American Journal of Epidemiology|February 7, 2001
Invited commentary: stopping polio immunizationH F Hull, R B Aylward, J Milstien
Developments in Biological Standardization|January 1, 1996
WHO activities towards the three Rs in the development and control of biological productsJ Milstien, V Grachev, A Padilla, et al.
Biologicals : Journal of the International Association of Biological Standardization|March 1, 1994
The relationship between dose and response of standard measles vaccinesJ L Diaz-Ortega, T Forsey, C J Clements, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Developments in Biologicals|April 8, 2003
Regulatory processes and three Rs alternativesJ Milstien
Indian Pediatrics|February 15, 2001
Vaccine vial monitorsJ Milstien
Lancet (London, England)|April 23, 1999
Immunogenicity of low-dose plasma-derived hepatitis B vaccineM Kane, J Milstien
Developments in Biologicals|April 8, 2003
Implementation of three Rs methods in 3rd World countriesJ L Di Fabio, J Milstien
Vaccine|August 1, 1997
A systematic method for evaluating the potential viability of local vaccine producersJ Milstien, A Batson, W Meaney
Tropical and Geographical Medicine|January 1, 1993
A global overview and hope for the eradication of poliomyelitis by the year 2000N Ward, J Milstien, H Hull, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|July 1, 1978
Characteristics of bacteriophage phiV-1 isolated from live virus vaccinesR Haselkorn, S Schichman, J Milstien, et al.
American Journal of Epidemiology|February 7, 2001
Invited commentary: stopping polio immunizationH F Hull, R B Aylward, J Milstien
Developments in Biological Standardization|January 1, 1996
WHO activities towards the three Rs in the development and control of biological productsJ Milstien, V Grachev, A Padilla, et al.
Biologicals : Journal of the International Association of Biological Standardization|March 1, 1994
The relationship between dose and response of standard measles vaccinesJ L Diaz-Ortega, T Forsey, C J Clements, et al.
Pageof 2